Positive effects of short-term growth hormone treatment on lean body mass and BMC after a hip fracture: A double-blind placebo-controlled pilot study in 20 patients

Acta Orthopaedica Scandinavica

Volumn 75, Issue 4, 2004, Pages 394-401

  Hedström, Margarete ^a   Sääf, Maria ^b   Brosjö, Eva ^a   Hurtig, Carolin ^a   Sjöberg, Kerstin ^c   Wesslau, Ann ^a   Dalén, Nils ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Danderyd Geriatric Clinic NLPO   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PLACEBO; SOMATOMEDIN C;

ARTICLE; BONE MINERAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIP FRACTURE; HUMAN; MALE; MEDICAL ASSESSMENT; POSTOPERATIVE PERIOD; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RANDOMIZATION; REDUCTION; SHORT COURSE THERAPY;

EID: 4444283270     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016470410001141-1     Document Type: Article

References (41)

1. Akner G, Cederholm T. Treatment of protein-energy malnutrition in chronic non-malignant disorders. Am J Clin Nutrition 2001; 74: 6-24.
2. Andreassen T T, Jorgensen P H, Flyvbjerg A, Orskov H, Oxlund H. Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res 1995; 10: 1057-67.
3. Berglund-Rödén M, Swierstra B A, Wingstrand H, Thorngren K G. Prospective comparison of hip fracture treatment: 856 cases followed for 4 months in the Netherlands and Sweden. Acta Orthop Scand 1994; 65: 287-94.
4. Bravenboer N, Holzmann P, De Boer H, Roos J C, van Der Veen E A, Lips P. The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH deficient men. J Clin Endocrinol Metab 1997; 82: 1818-22.
5. Brixen K, Kassem M, Fink Eriksen E, Nielsen H, Flyvbjerg A, Mosekilde L. Growth hormone (GH) and adult bone remodeling: the potential use of GH in treatment of osteoporosis. J Pediatr Endocinol 1993; 6: 65-71.
6. Bäckman E, Öberg B. Isokinetic muscle torque in the dorsiflexors of the ankle in children 6-15 years of age. Scand J Rehab Med 1989; 21: 97-103.
7. Cummings S R, Black D M, Nevitt M C, Browner W S, Cauley J A, Ensrud K, Genant H K, Palermo L, Scott J, Vogt T M. Bone density at various sites for prediction of hip fractures. Lancet 1993; 341: 72-5.
8. Degerblad M, Bengtsson B Å, Bramnert M, Johnell J, Manhem P, Rosen T, Thorén M. Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy. Eur J Endocrinol 1995; 133: 180-8.
9. Fryburg D, Barret E. Growth hormone acutely stimulates skeletal muscle but not whole body protein synthesis in humans. Metabolism 1993; 42: 1223-7.
10. Gillberg P, Mallmin H, Petren-Mallmin M, Ljunghall S, Nilsson A G. Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis. J Clin Endocrinol Metab 2002; 87: 4900-6.
11. Hall K, Lundin G, Póvoa G. Serum levels of low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa. Acta Endocrinol 1988; 118: 321-6.
12. Hedström M, Sääf M, Dalén N. Low IGF-I levels in hip fracture patients. A comparison of 20 coxarthrotic and 23 hip fracture patients. Acta Orthop Scand 1999; 70: 145-8.
13. Hilding A, Hall K, Wivall-Helleryd I-L, Sääf M, Melin A-L, Thorén M. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 1999; 84: 2013-9.
14. Holloway L, Butterfield G, Hintz R, Gesundheit N, Marcus R. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. Clin Endocrinol Metab 1994; 79: 470-9.
15. Jiang Z M, He G Z, Zhang S Y, Wang X R, Yang N F, Zhu Y, Wilmore D W. Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg 1989; 10: 513-25.
16. Johannsson G, Grimby G, Stibrant Sunnerhagen K, Bengtsson B Å. Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH deficient adults. J Clin Endocrinol Metab 1997; 82: 2877-84.
17. Johansson A, Edén-Engström B, Ljunghall S, Karlsson A, Burman P. Gender differences in the effects of long term growth hormone treatment on bone in adults with GH deficiency. J Clin Endocrinol Metab 1999; 84: 2002-7.
18. Jorgensen J, Thulesen L, Ingeman-Hansen T, Pedersen S, Joregensen J, Skakkebaek N, Christiansen J. Beneficial effects of growth hormone treatment in GH-deficient adults. The Lancet 1989; 3: 1221-5.
19. Karantanas A, Kalef-Ezra J, Glaros D. Quantitative computed tomography for bone mineral measurement: technical aspects, dosimetry, normal data and clinical applications. Brit J Radiology 1991; 64: 298-304.
20. Karlsson M, Nilsson J Å, Sernbo I, Redlund-Johnell I, Johnell O, Obrant K. Changes of bone mineral mass and soft tissue composition after hip fracture. Bone 1996; 18: 19-22.
21. Landin-Wilhelmsen K, Nilsson A, Bosaeus I, Bengtsson B Å. Growth hormone increases bone mineral content in postmenopausal osteoporosis: A randomized placebo-controlled study. J Bone Miner Res 2003; 18 (3): 393-405.
22. Lange K, Isaksson F, Höjby Rasmussen M, Bülow J, Juul A, Kjaer M. GH administration and discontinuation in healthy elderly men; effects on body composition, GH related serum markers, resting heart rate and oxygen uptake. Clin Endocrinol 2001; 55: 77-86.
23. Lumbers M, Driver L T, Howland R J, Older M W, Williams C M. Nutritional status and clinical outcome in elderly female surgical orthopedic patients. Clin Nutr 1996; 15: 101-7.
24. Meunier P J, Boivin G. Bone mineral density reflects bone mass but also the degree of mineralization of bone: therapeutic implications. Bone 1997; 21: 373-7.
25. Münzer T, Harman M, Hees P, Shapiro E, Christmas C, Bellantoni M, Stevens T, O'Connor K, Pabst K, St Clair C, Sorkin J, Blackman M. Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. J Clin Endocrinol Metab 2001; 86: 3604-10.
26. Murray R D, Skillicorn C J, Howell S J, Lissett C A, Rahim A, Shalet S M. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults. Clin Endocrinol 1999; 50: 749-57.
27. Neander G, Adolphson P, von Sivers K, Dahlborn M, Dalén N. Bone and muscle mass after femoral neck fracture. A controlled quantitative computed tomography study of osteosynthesis versus primary total hip arthroplasty. Arch Orhop Trauma Surg 1997; 116: 470-4.
28. Papadakis M, Grady D, Black D, Tierney M, Gooding G, Schabelan M, Grunfeld C. Growth hormone replacement in healthy older improves body composition but not functional capacity. Ann Intern Med 1996, 124: 708-16.
29. Petersen S, Holaday N, Jeevanandam M. Enhancement of protein synthesis efficiency in parentally fed trauma victims by adjutant recombinant human growth hormone. J Trauma 1994; 36: 726-33.
30. Rudman D, Feller A, Nagraj H, Gergans G, Lalitha P, Goldberg A, Schlenker R, Cohn L, Rudman I, Mattson D. Effects of growth hormone in men over 60 years old. N Engl Med 1990; 323: 1-6.
31. Slosman D O, Casez J P, Pichard C, Rochat T, Fery F, Rizzoli R et al. Assessment of whole-body composition with dual-energy x-ray absorptiometry. Radiology 1992; 185: 593-8.
32. Symreng T. Arm anthropometry in a large reference population and in surgical patients. Clin Nutr 1982; 1: 211-9.
33. Sääf M, Hilding A, Thorén M, Troell S, Hall K. Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study. Eur J Endocrinol 1999; 140: 390-9.
34. Takala J, Ruokonen E, Webster N R, Nielasen M S, Zandstra D F, Vundenlinckx G, Hinds C J. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785-92.
35. Thompson J, Butterfield G, Hintz L, van Loan M, Ghiron L, Hoffman A. The effects of recombinant human insulin-like growth factor I and growth hormone on body composition in elderly women. J Clin Endocrinol Metab 1995; 80: 1845-52.
36. Van der Lely A, Lamberts S, Jauch K, Swiersta B, Hertlein H, De Vries D, Birkett M, Bates P, Blum W, Attanasio A. Use of human GH in elderly patients with accidental hip fracture. Eur J Endocrinol 2000; 143: 585-92.
37. Vara-Thorbeck R, Guerrero J A, Resell J, Ruiz-Requena E, Capitán J M. Exogenous growth hormone: Effects on the catabolic response to surgically produced acute stress and on postoperative immune function. World J Surg 1993; 17: 530-8.
38. Vellas B, Conceiacao J, LaFont B, Garry P J, Adoue D, Albarede J L. Malnutrition and falls. Lancet 1990; 336: 1447.
39. Välimäki M, Salmela P, Salmi J, Viikari J, Kataja M, Turunen H, Soppi E. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH deficient adults. Eur J Endocrinol 1999; 140: 545-54.
40. Weissberger A J, Anastasiadis A D, Sturgess I, Martin F C, Smith M A, Sonksen P H. Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement. Clin Endocrinol 2003; 58: 99-107.
41. Weissman C. The metabolic response to stress: an overview and update. Anestesiology 1990; 73: 308-27.